TEVA:TLV
Teva Pharmaceutical Industries Limited
ILA 12,640.00
arrow_downward
-0.78%(-100.00) 1D
Oct 14, 1:33:30 PM GMT+3 · ILA
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TEVA...
Open
ILA 12,730.00
High
ILA 12,730.00
Low
ILA 12,620.00
Mkt. cap
148.05B
Avg. vol.
1.08M
Volume
328.28K
P/E ratio
68.48
52-wk high
ILA 12,730.00
52-wk low
ILA 6,207.00
EPS
ILA 1.85
Shares outstanding
1.17B
No. of employees
32K
Open
ILA 12,730.00
High
ILA 12,730.00
Low
ILA 12,620.00
Mkt. cap
148.05B
Avg. vol.
1.08M
Volume
328.28K
P/E ratio
68.48
52-wk high
ILA 12,730.00
52-wk low
ILA 6,207.00
EPS
ILA 1.85
Shares outstanding
1.17B
No. of employees
32K
News stories
From web sources and news partners
ad-hoc-news.de
·
41 minutes ago
Barclays keeps Buy rating for Teva stock at USD 42.00
ad-hoc-news.de
·
1 day ago
JPMorgan raised target for Teva stock to USD 50.00
Profile
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
About Teva Pharmaceutical Industries Limited
CEORichard Francis
Employees32K
FoundedFeb 13, 1944
Headquarters-
SectorPharmaceutical industry
Websiteteva.co.il
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 4.48B | 4.71B | 3.98B | 4.14B |
Cost of goods sold | 2.18B | 2.06B | 2.01B | 1.99B |
Cost of revenue | 2.18B | 2.06B | 2.01B | 1.99B |
Research and development expenses | 256.00M | 267.00M | 222.00M | 970.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 973.00M | 1.12B | 1.00B | 1.03B |
Operating expense | 1.24B | 1.37B | 1.21B | 1.99B |
Total operating expenses | 3.41B | 3.43B | 3.22B | 3.98B |
Operating income | 1.07B | 1.28B | 763.00M | 167.00M |
Other non operating income | -27.00M | - | -13.00M | -69.00M |
EBT including unusual items | 648.00M | 90.00M | 436.00M | -455.00M |
EBT excluding unusual items | 832.00M | 1.08B | 547.00M | -57.00M |
Income tax expense | 214.00M | -390.00M | 67.00M | 121.00M |
Effective tax rate | 33.02% | -433.33% | 15.37% | -26.59% |
Other operating expenses | 9.00M | -17.00M | -14.00M | -18.00M |
Net income | 433.00M | 480.00M | 369.00M | -576.00M |
Net profit margin | 9.67% | 10.19% | 9.27% | -13.91% |
Earnings per share | 0.78 | 0.96 | 0.53 | 0.02 |
Interest and investment income | - | 92.00M | - | - |
Interest expense | -205.00M | -280.00M | -191.00M | -186.00M |
Net interest expenses | -205.00M | -188.00M | -191.00M | -186.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 1.32B | 1.54B | 1.00B | 408.00M |
Gain or loss from assets sale | - | - | -8.00M | -12.00M |